Forest Sues To Keep Generic Lexapro Off Market

Law360, New York (July 11, 2006, 12:00 AM EDT) -- Forest Laboratories Inc. and its Danish licensing partner H. Lundbeck A/S have filed their third separate lawsuit to stop a generic version of the blockbuster antidepressant drug Lexapro from entering the market.

In its complaint filed Monday in the U.S. District Court in Detroit, Forest accused Caraco Pharmaceutical Laboratories Ltd. of infringing its patent when it applied to the Food and Drug Administration for approval to sell a generic version of Lexapro.

Though the FDA has not decided whether to approve the request, Forest argued that...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.